"Optic Nerve Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Benign and malignant neoplasms that arise from the optic nerve or its sheath. OPTIC NERVE GLIOMA is the most common histologic type. Optic nerve neoplasms tend to cause unilateral visual loss and an afferent pupillary defect and may spread via neural pathways to the brain.
| Descriptor ID |
D019574
|
| MeSH Number(s) |
C04.588.614.300.600 C04.588.614.596.240.240 C10.292.225.800 C10.292.700.500 C10.551.360.500 C10.551.775.250.500 C11.640.544
|
| Concept/Terms |
Optic Nerve Neoplasms- Optic Nerve Neoplasms
- Neoplasm, Optic Nerve
- Optic Nerve Neoplasm
- Neoplasms, Optic Nerve
Malignant Optic Nerve Neoplasm- Malignant Optic Nerve Neoplasm
- Tumor, Optic Nerve, Malignant
- Tumor, Malignant, Optic Nerve
- Malignant Optic Nerve Tumor
- Optic Nerve Tumor, Malignant
Benign Optic Nerve Neoplasm- Benign Optic Nerve Neoplasm
- Neoplasm, Benign, Optic Nerve
- Tumor, Optic Nerve, Benign
- Optic Nerve Neoplasm, Benign
- Tumor, Benign, Optic Nerve
- Benign Optic Nerve Tumor
- Neoplasm, Optic Nerve, Benign
|
Below are MeSH descriptors whose meaning is more general than "Optic Nerve Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Optic Nerve Neoplasms".
This graph shows the total number of publications written about "Optic Nerve Neoplasms" by people in this website by year, and whether "Optic Nerve Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 3 | 0 | 3 |
| 2000 | 3 | 0 | 3 |
| 2001 | 3 | 0 | 3 |
| 2002 | 3 | 0 | 3 |
| 2003 | 2 | 0 | 2 |
| 2004 | 4 | 0 | 4 |
| 2005 | 4 | 0 | 4 |
| 2006 | 2 | 1 | 3 |
| 2007 | 1 | 0 | 1 |
| 2008 | 2 | 0 | 2 |
| 2009 | 2 | 0 | 2 |
| 2011 | 3 | 1 | 4 |
| 2012 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2016 | 2 | 0 | 2 |
| 2019 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Optic Nerve Neoplasms" by people in Profiles.
-
Shields JA, Demirci H, Mashayekhi A, Eagle RC, Shields CL. Melanocytoma of the optic disk: A review. Indian J Ophthalmol. 2019 12; 67(12):1949-1958.
-
McCormack E, Mathkour M, Riffle J, Amenta PS. Lymphoma of the Optic Apparatus in an Immunocompetent Patient: A Case Report and Review of the Literature. World Neurosurg. 2019 Jul; 127:269-274.
-
Turkoglu EB, Say EA, Shields CL. Spontaneous Devascularization and Detachment of Optic Nerve Hemangioblastoma in a Patient With Von Hippel-Lindau Disease. JAMA Ophthalmol. 2016 09 08; 134(9):e161119.
-
Abdellatief A, Pulido JS, Bartley GB, Salomao DR, Quinn TA. UVEAL MELANOMA EXTENSION TO THE OPTIC CHIASM. Retin Cases Brief Rep. 2016; 10(1):1-5.
-
Avery RA, Hwang EI, Ishikawa H, Acosta MT, Hutcheson KA, Santos D, Zand DJ, Kilburn LB, Rosenbaum KN, Rood BR, Schuman JS, Packer RJ. Handheld optical coherence tomography during sedation in young children with optic pathway gliomas. JAMA Ophthalmol. 2014 Mar; 132(3):265-71.
-
Shukla SY, Shields JA, Eagle RC, Shields CL. Transformation of optic disc melanocytoma into melanoma over 33 years. Arch Ophthalmol. 2012 Oct; 130(10):1344-7.
-
Mazzuca DE, Shields CL, Sinha N, Bianciotto CG, Fox G, Shields JA. Progressive retinal invasion and vitreous seeding from optic disc melanocytoma. Clin Exp Ophthalmol. 2012 Jan-Feb; 40(1):e123-5.
-
Kaliki S, Shields CL, Shah SU, Eagle RC, Shields JA, Leahey A. Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma. Arch Ophthalmol. 2011 Nov; 129(11):1422-7.
-
Eagle RC, Shields CL, Bianciotto C, Jabbour P, Shields JA. Histopathologic observations after intra-arterial chemotherapy for retinoblastoma. Arch Ophthalmol. 2011 Nov; 129(11):1416-21.
-
Simao LM, Dine Sultan EN, Hall JK, Reardon DA, Bhatti MT. Knee deep in the nerve. Surv Ophthalmol. 2011 Jul-Aug; 56(4):362-70.